February 14, 2017 / 12:18 PM / 6 months ago

BRIEF-Amag Pharmaceuticals, Endoceutics enter into license agreement

Feb 14 (Reuters) - Amag Pharmaceuticals Inc :

* Amag and Endoceutics enter into an exclusive U.S. license agreement for intrarosa (prasterone)

* Amag Pharmaceuticals Inc says "Endoceutics plans to put an additional $20 million toward supporting educational programs in 2017"

* Amag Pharmaceuticals Inc- Amag expects to launch intrarosa in U.S. In mid-2017

* Amag Pharma-under terms of deal, at closing, co to pay endoceutics $50 million of total consideration, issue endoceutics 600,000 unregistered shares of co Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below